The Latest Breaking News from Mangeet Kaur BounsMangeet

The financial services industry is well-positioned for robust profitability and expansion thanks to sustained demand and widespread adoption of digital technologies. Moreover, financial institutions generally benefit from higher interest rates. So, let’s determine if you should buy, hold, or sell financial stocks Mastercard (MA) and Equifax (EFX). Read on to…

Micron (MU) posted a significant year-over-year decline in revenue and incurred massive losses in the third quarter of 2023. Further, analysts appear bearish about its outlook amid China’s ban on its chips and the demand-supply imbalance. But given the stock’s more than 18% gain over the past six months, let’s…

Google parent Alphabet’s (GOOGL) fiscal 2023 second-quarter revenue and earnings surpassed analyst estimates. Furthermore, analysts are bullish about the company’s prospects due to its innovative products and services offerings, rising AI investments, and dominance in the internet search market. Amid this, let’s review the stock’s mid-September buying potential. Keep reading….

Amid a growing shift toward digitalization worldwide, increased internet penetration and supportive government initiatives to boost widespread internet accessibility would drive the internet services industry’s prospects. Thus, internet stocks Shopify (SHOP) and Wix.com (WIX) are well-placed for significant growth. But which of these stocks is a better buy now? Keep…

Adobe (ADBE) delivered solid top-and bottom-line growth in the last reported quarter and raised its annual targets. Moreover, analysts seem bullish about the company’s prospects due to its innovative product offerings, partnerships, and market dominance in the software sector. So, let’s determine if this stock is a buy or sell…

Oracle (ORCL) surpassed analysts’ estimates on the top and bottom lines for the last reported quarter. Further, the company’s long-term prospects appear bright, driven by its product innovation and diversification, strategic partnerships, and significant advances in AI. However, given its elevated valuation and market weakness, is this stock a buy,…

The pharmaceutical industry’s prospects look bright, fueled by a rapidly aging population, the rising prevalence of chronic diseases, consistent R&D efforts backed by government funding, and digital transformation. Pharma stocks Relay Therapeutics (RLAY) and Perrigo Company (PRGO) should benefit from the industry tailwinds. But let’s find out which stock holds…

Thanks to high chip demand for several applications, rising adoption of cutting-edge technologies, and lucrative government initiatives and funding, the semiconductor industry’s outlook appears robust. Prominent chip stocks Advanced Micro Devices (AMD) and Applied Materials (AMAT) should benefit from the industry tailwinds. But let’s find out which is the better…

DocuSign (DOCU) posted solid first-quarter results, and the company’s growth prospects look promising, driven by robust demand for its flagship product, eSignature, diversification in its product portfolio, and strategic partnerships. So, let’s find out if this stock is a buy before the second-quarter earnings release. Read on to know more….